Search

Objective: In order to improve the energy efficiency of the transcritical two stage CO2 refrigeration system, the conventional exergy analysis and advanced exergy analysis of the system were conducted. Methods: Advanced exergy analysis provides more valuable information on the interaction between system components and the potential for component improvement by splitting the exergy destruction into endogenous/exogenous and unavoidable/avoidable parts. Results: The results indicated that the transcritical two stage CO2 refrigeration system had significant potential for efficiency improvement. The priority of the optimized components from conventional and advanced exergy analysis was different. The advanced exergy analysis showed that performance optimization of the high-pressure stage compressor, low-pressure stage compressor and evaporator were the focus of improving system energy efficiency. Conclusion: The endogenous avoidable exergy destruction of the high-pressure stage compressor, low-pressure stage compressor and evaporator accounted for 20.9%, 15.2% and 36.5% of the endogenous avoidable exergy destruction of the system, respectively. The improvement of the high-pressure stage compressor, low-pressure stage compressor and evaporator are able to reduce their exergy destruction by 58.8%, 49.3% and 90.2%, respectively. The conventional exergy analysis cannot provide such recommendations.

Bladder cancer (BC) is the most common urinary tract malignancy. Identifying biomarkers that predict prognosis and immune function in patients with BC can enhance our understanding of its pathogenesis and provide valuable guidance for diagnosis and treatment. Our findings indicate that increased ITGB1 expression is associated with higher clinical grade and stage, establishing ITGB1 as an independent prognostic risk factor for BC. Enrichment analysis revealed that the function of ITGB1 in BC was linked to the extracellular matrix. The experimental results showed that ITGB1 knockdown in the BC cell lines 5637 and RT112 reduced their proliferation, migration, and invasion. Furthermore, ITGB1 suppression promotes apoptosis in BC cells by inhibiting the PI3K‐AKT pathway. A prognostic risk model incorporating CES1, NTNG1, SETBP1, and AIFM3 was developed based on ITGB1, this model can accurately predict patient prognosis based on immunological status. In conclusion, this study shows that knockdown of ITGB1 can restrain the migratory and invasive capabilities of BC cells and accelerate apoptosis, and this role might be associated with PI3K‐AKT, highlighting its potential as a diagnostic marker and therapeutic target for BC. [ABSTRACT FROM AUTHOR]